Clayton Dubilier & Rice, a private investment firm, agreed to acquire Cynosure, a medical aesthetics systems and technologies provider, from Hologic, an innovative medical technology company, for $205m. Net of these adjustments, Hologic expects net cash proceeds of approximately $138m. "Cynosure is a market leader with a comprehensive product portfolio and a track record of more than 25 years of science-driven healthcare innovation. In addition to a targeted tuck-in acquisition strategy, we expect to continue to invest behind the company's strong brand and large global installed base to accelerate growth via expanded sales & marketing efforts and bring new products and technologies to market that both enhance the company's value proposition to its channel partners and improve clinical outcomes for end consumers," Derek Strum, CD&R Partner.